GlassScriptPhysician profile
Timothy F Pingree
NPI 1386734457
$1,744.59
in general payments reported to CMS, 2019-2025
18 companies · $826 in 2025
The $826 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $197 · 2021: $13.44 · 2023: $94.15 · 2024: $478 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $328.21 | 2019-2025 | |
| Stryker Corporation | $280.03 | 2020-2025 | Na, Sonopet Iq, Core |
| Medtronic, INC. | $270.94 | 2023-2025 | Propel, Nuvent |
| Glaxosmithkline, LLC. | $178.29 | 2021-2025 | Nucala |
| Aerin Medical INC. | $152.37 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $142.97 | 2023-2025 | Dupixent |
| Optinose US, INC. | $84.04 | 2019-2020 | |
| Intersect Ent, INC. | $64.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $39.19 | 2025 | Tezspire |
| Phadia US INC. | $30.75 | 2019-2024 | Immunocap |
| Inspire Medical Systems, INC. | $29.57 | 2024 | Inspire |
| Neurent Medical Limited | $28.88 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Arbor Pharmaceuticals, INC. | $27.79 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $22.58 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $18.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.23 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.26 | 2024 | Unithroid |
| Kaleo, INC. | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Pingree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.